{
     "PMID": "20128952",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20110901",
     "LR": "20161020",
     "IS": "1469-5111 (Electronic) 1461-1457 (Linking)",
     "VI": "13",
     "IP": "9",
     "DP": "2010 Oct",
     "TI": "Locus coeruleus stimulation and noradrenergic modulation of hippocampo-prefrontal cortex long-term potentiation.",
     "PG": "1219-31",
     "LID": "10.1017/S1461145709991131 [doi]",
     "AB": "Stimulation of the subiculum/CA1 of the hippocampal formation evokes monosynaptic field potentials in the prefrontal cortex (PFC). High-frequency stimulation of the hippocampus (HPC) can induce long-term potentiation (LTP) in this hippocampo-prefrontal cortical (hippo-PFC) pathway. Previous studies have shown that dopamine and serotonin modulate hippo-PFC LTP. Here, we investigated whether the locus coeruleus (LC) and noradrenaline (NA) can modulate LTP in the rat hippo-PFC pathway. Stimulation of the LC in combination with stimulation of the HPC increased hippo-PFC LTP. Infusion of lidocaine into the LC reduced hippo-PFC LTP. Administration of the noradrenaline reuptake inhibitor, nisoxetine or the alpha2 adrenoceptor antagonist, idazoxan prior to high-frequency stimulation of the HPC enhanced hippo-LTP. In contrast, administration of clonidine, an alpha2 adrenoceptor agonist, impaired hippo-PFC LTP. Partial noradrenergic (NAergic) lesioning with DSP-4 also impaired hippo-PFC LTP. In conclusion, the LC and NAergic mechanisms modulate hippo-PFC LTP.",
     "FAU": [
          "Lim, Ee Peng",
          "Tan, Chay Hoon",
          "Jay, Therese M",
          "Dawe, Gavin S"
     ],
     "AU": [
          "Lim EP",
          "Tan CH",
          "Jay TM",
          "Dawe GS"
     ],
     "AD": "Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20100204",
     "PL": "England",
     "TA": "Int J Neuropsychopharmacol",
     "JT": "The international journal of neuropsychopharmacology",
     "JID": "9815893",
     "RN": [
          "0 (Adrenergic Agents)",
          "0 (Adrenergic alpha-2 Receptor Antagonists)",
          "0 (Adrenergic alpha-Agonists)",
          "0 (Benzylamines)",
          "333DO1RDJY (Serotonin)",
          "MN3L5RMN02 (Clonidine)",
          "PQ1P7JP5C1 (DSP 4)",
          "VTD58H1Z2X (Dopamine)",
          "X4W3ENH1CV (Norepinephrine)",
          "Y310PA316B (Idazoxan)"
     ],
     "SB": "IM",
     "MH": [
          "Adrenergic Agents/metabolism/pharmacology",
          "Adrenergic alpha-2 Receptor Antagonists/metabolism/pharmacology",
          "Adrenergic alpha-Agonists/metabolism/pharmacology",
          "Animals",
          "Benzylamines/metabolism/pharmacology",
          "Clonidine/metabolism/pharmacology",
          "Dopamine/metabolism/physiology",
          "Hippocampus/*drug effects/metabolism/physiology",
          "Idazoxan/metabolism/pharmacology",
          "Locus Coeruleus/*drug effects/physiology",
          "*Long-Term Potentiation/drug effects",
          "Male",
          "Norepinephrine/*metabolism",
          "Prefrontal Cortex/*drug effects/*metabolism/physiology",
          "Rats",
          "Rats, Sprague-Dawley",
          "Serotonin/metabolism/physiology"
     ],
     "EDAT": "2010/02/05 06:00",
     "MHDA": "2011/09/02 06:00",
     "CRDT": [
          "2010/02/05 06:00"
     ],
     "PHST": [
          "2010/02/05 06:00 [entrez]",
          "2010/02/05 06:00 [pubmed]",
          "2011/09/02 06:00 [medline]"
     ],
     "AID": [
          "S1461145709991131 [pii]",
          "10.1017/S1461145709991131 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Int J Neuropsychopharmacol. 2010 Oct;13(9):1219-31. doi: 10.1017/S1461145709991131. Epub 2010 Feb 4.",
     "term": "hippocampus"
}